#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA707817	F	Tested for the effective dose required to inhibit systemic MCMV in infected mice	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
2.	ALA707818	F	In vitro antiviral activity tested against MCMV Smith strain by plaque reduction assay in mouse embryo fibroblasts.	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
3.	ALA707819	F	Tested for mean day to death of nonsurvivors against systemic MCMV infection in mice at 1.9 mg/kg per day	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
4.	ALA873333	F	Number of survivors per number of systemic MCMV infected mice treated with 11.2 mg/kg per day; 15/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
5.	ALA710848	F	Number of survivors per number of systemic MCMV infected mice treated with 3.8 mg/kg per day; 10/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
6.	ALA710849	F	Number of survivors per number of systemic MCMV infected mice treated with 33.4 mg/kg per day; 15/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
7.	ALA710850	F	Tested for the effective dose required to inhibit systemic MCMV in infected mice	Murid betaherpesvirus 1	2		organism-based format	Scientific Literature
8.	ALA710851	F	Tested for mean day to death of nonsurvivors against systemic MCMV infection in mice at 100 mg/kg/day	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
9.	ALA710852	F	Tested for mean day to death of nonsurvivors against systemic MCMV infection in mice at 11.2 mg/kg/day	Murid betaherpesvirus 1	2		organism-based format	Scientific Literature
10.	ALA711013	F	Tested for mean day to death of nonsurvivors against systemic MCMV infection in mice at 3.8 mg/kg/day	Murid betaherpesvirus 1	2		organism-based format	Scientific Literature
11.	ALA711014	F	Tested for mean day to death of nonsurvivors against systemic MCMV infection in mice at 33.4 mg/kg/day	Murid betaherpesvirus 1	2		organism-based format	Scientific Literature
12.	ALA711015	F	Number of survivors per number of systemic MCMV infected mice treated with 100 mg/kg/day; 13/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
13.	ALA711016	F	Number of survivors per number of systemic MCMV infected mice treated with 100 mg/kg/day; 15/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
14.	ALA711017	F	Number of survivors per number of systemic MCMV infected mice treated with 11.2 mg/kg/day; 14/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
15.	ALA711018	F	Number of survivors per number of systemic MCMV infected mice treated with 11.2 mg/kg/day; 9/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
16.	ALA711019	F	Number of survivors per number of systemic MCMV infected mice treated with 3.8 mg/kg/day; 4/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
17.	ALA710010	F	Number of survivors per number of systemic MCMV infected mice treated with 3.8 mg/kg/day; 7/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
18.	ALA878581	F	Number of survivors per number of systemic MCMV infected mice treated with 33.4 mg/kg/day; 13/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
19.	ALA710011	F	Number of survivors per number of systemic MCMV infected mice treated with 33.4 mg/kg/day; 14/15	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature
20.	ALA710012	F	In vitro antiviral activity tested against herpesvirus, MCMV, Smith strain by plaque reduction assay in mouse embryo fibroblasts	Murid betaherpesvirus 1	1		organism-based format	Scientific Literature